[HTML][HTML] Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG …

I Law, NL Albert, J Arbizu, R Boellaard… - European journal of …, 2019 - Springer
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

NL Albert, N Galldiks, BM Ellingson… - The Lancet …, 2024 - thelancet.com
Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …

[HTML][HTML] The utility of conventional amino acid PET radiotracers in the evaluation of glioma recurrence also in comparison with MRI

G Santo, R Laudicella, F Linguanti, AG Nappi… - Diagnostics, 2022 - mdpi.com
Aim: In this comprehensive review we present an update on the most relevant studies
evaluating the utility of amino acid PET radiotracers for the evaluation of glioma recurrence …

[HTML][HTML] Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma

M Harat, J Rakowska, M Harat, T Szylberg… - Nature …, 2023 - nature.com
Accurate determination of the extent and grade of adult-type diffuse gliomas is critical to
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …

[HTML][HTML] Predicting IDH genotype in gliomas using FET PET radiomics

P Lohmann, C Lerche, EK Bauer, J Steger, G Stoffels… - Scientific reports, 2018 - nature.com
Mutations in the isocitrate dehydrogenase (IDH mut) gene have gained paramount
importance for the prognosis of glioma patients. To date, reliable techniques for a …

[HTML][HTML] Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Z Li, L Kaiser, A Holzgreve, VC Ruf… - European journal of …, 2021 - Springer
Purpose To evaluate radiomic features extracted from standard static images (20–40 min pi),
early summation images (5–15 min pi), and dynamic [18 F] FET PET images for the …

18F-FET PET imaging in differentiating glioma progression from treatment-related changes: a single-center experience

GD Maurer, DP Brucker, G Stoffels… - Journal of nuclear …, 2020 - Soc Nuclear Med
In glioma patients, differentiation between tumor progression (TP) and treatment-related
changes (TRCs) remains challenging. Difficulties in classifying imaging alterations may …

[HTML][HTML] Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi …

N Barry, RJ Francis, MA Ebert, ES Koh… - European Journal of …, 2023 - Springer
Abstract Purpose The O-(2-[18F]-fluoroethyl)-l-tyrosine (FET) PET in Glioblastoma (FIG) trial
is an Australian prospective, multi-centre study evaluating FET PET for glioblastoma patient …

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

M Unterrainer, DF Fleischmann, F Vettermann… - European journal of …, 2020 - Springer
Background The 18-kDa translocator protein (TSPO) is overexpressed in brain tumours and
represents an interesting target for glioma imaging. 18 F-GE-180, a novel TSPO ligand, has …

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

M Unterrainer, DF Fleischmann, C Diekmann… - European journal of …, 2019 - Springer
Background PET represents a valuable tool for glioma imaging. In addition to amino acid
tracers such as 18 F-FET, PET targeting the 18-kDa mitochondrial translocator-protein …